NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $1.10 +0.03 (+2.33%) Closing price 04:00 PM EasternExtended Trading$1.09 -0.01 (-0.73%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NMTC alerts:Sign Up Key Stats Today's Range$1.05▼$1.1450-Day Range$0.99▼$2.1852-Week Range$0.96▼$6.12Volume108,327 shsAverage Volume138,724 shsMarket Capitalization$10.02 millionP/E RatioN/ADividend YieldN/APrice Target$7.33Consensus RatingHold Company Overview NeuroOne Medical Technologies Corporation is a medical device company focused on developing and commercializing technologies for recording, monitoring, and treating neurological disorders. Its products are designed for use by neurosurgeons and neurologists in procedures involving the brain and nervous system, including the diagnosis and treatment of epilepsy and other neurological conditions. The company’s product portfolio includes the Evo cortical and stereoelectroencephalography (sEEG) electrode systems, which are used to record electrical activity in the brain. NeuroOne is also developing the OneRF Ablation System, a technology intended to deliver radiofrequency energy to targeted areas of the brain for therapeutic procedures. The company has emphasized electrode designs intended to support minimally invasive procedures and provide recording and therapeutic capabilities. NeuroOne was founded in 2009 and is headquartered in Eden Prairie, Minnesota. Its products are primarily developed for the U.S. neurosurgical market, with potential applications in international markets as regulatory approvals and commercial opportunities develop. The company is led by Chief Executive Officer and President Dave Rosa, who has been involved in the development and commercialization of medical device technologies.AI Generated. May Contain Errors. Read More NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreNMTC MarketRank™: 3.096052631575 of 5 starsNeuroOne Medical Technologies scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialNeuroOne Medical Technologies has a consensus price target of $7.33, representing about 566.7% upside from its current price of $1.10.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 2 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for NeuroOne Medical Technologies are expected to decrease in the coming year, from ($0.39) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.23% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 1.19, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently increased by 135.85%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.44 News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for NeuroOne Medical Technologies this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for NMTC on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat Follows3 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $66,999.00 in company stock, which represents 0.6686% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,999.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.80% of the stock of NeuroOne Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMTC Stock News HeadlinesNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Stock Rated "Hold" by Wall Street AnalystsOctober 13 at 8:17 AM | americanbankingnews.comNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Shares Shorted: Short Interest Up 135.8% in SeptemberOctober 13 at 6:02 AM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 13 at 1:00 AM | Base Camp Trading (Ad)TriSalus Life Sciences (NASDAQ:TLSI) and NeuroOne Medical Technologies (NASDAQ:NMTC) Critical ContrastOctober 13 at 3:45 AM | americanbankingnews.comNeuroOne Medical Technologies Corporation Joins Dartmouth College-Led Research Team On $1 Million NIH Grant To Advance Neurotransmitter Sensing TechnologyOctober 10 at 5:40 PM | marketscreener.comMNeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing TechnologyOctober 8, 2026 | markets.businessinsider.comNeuroOne (NASDAQ: NMTC) secures a $4.5M order as revenue climbs againOctober 7, 2026 | americanbankingnews.comNeuroOne Gains After Q4 Product Revenue Rises 38%October 5, 2026 | rttnews.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $4.5480 at the start of the year. Since then, NMTC stock has decreased by 75.8% and is now trading at $1.10. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) issued its quarterly earnings results on Thursday, August, 13th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.07. The firm earned $1.97 million during the quarter, compared to the consensus estimate of $2.17 million. NeuroOne Medical Technologies had a negative net margin of 71.50% and a negative trailing twelve-month return on equity of 128.12%. Read the conference call transcript. When did NeuroOne Medical Technologies' stock split? Shares of NeuroOne Medical Technologies reverse split on Wednesday, April 15th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 14th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did NeuroOne Medical Technologies IPO? NeuroOne Medical Technologies (NMTC) raised $500,000 in an IPO on Wednesday, May 26th 2021. The company issued 10,000,000 shares at $0.05 per share. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include NVIDIA (NVDA), Nokia (NOK), Advanced Micro Devices (AMD), NIO (NIO), Tesla (TSLA), Dell Technologies (DELL) and Lithium Americas (LAC). Company Calendar Last Earnings8/13/2026Today10/13/2026Next Earnings (Estimated)12/15/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 NMTC's financial health is in the Red zone, according to TradeSmith. NMTC has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.n1mtc.com Phone(952) 426-1383FaxN/AEmployees18Year FoundedN/APrice Target and Rating Average Price Target for NeuroOne Medical Technologies$7.33 High Price Target$9.00 Low Price Target$5.00 Potential Upside/Downside+566.7%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.95) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.61 million Net Margins-71.50% Pretax Margin-74.46% Return on Equity-128.12% Return on Assets-86.34% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio1.71 Sales & Book Value Annual Sales$12.10 million Price / Sales0.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book1.29Miscellaneous Outstanding Shares9,110,000Free Float8,031,000Market Cap$10.02 million OptionableOptionable Beta0.77 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:NMTC) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts